IV Secukinumab for AxSpa The FDA recently announced approval for intravenous secukinumab (Cosentyx) for adults with ps
Tweet Content
IV Secukinumab for AxSpa
The FDA recently announced approval for intravenous secukinumab (Cosentyx) for adults with psoriatic arthritis, ankylosing spondylitis, and non-radiographic spondylitis.
https://t.co/JhOvPIXOMN https://t.co/GoV62NjSmf
Show on Archive Page
On
Display in Search Results
On
PDQ
Off